Loading...
Reve Technologies, Inc.
BSSP•PNK
HealthcareBiotechnology
$0.00
$0.00(0.00%)
Reve Technologies, Inc. (BSSP) Stock Overview
Explore Reve Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for BSSPStats details for BSSP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for BSSPAnalyst Recommendations details for BSSP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.
CEO
Mr. Dennis R. Alexander
Headquarters
300 South El Camino Real, San Clemente, CA
Founded
2012